#48 - Michael Oleksiw, CEO at Pleio
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
#48 - Michael Oleksiw, CEO at Pleio
-
Narrated by:
-
By:
About this listen
Join us on the latest episode! Our Guest: Michael Oleksiw, CEO at Pleio.
What you'll get out of this episode:
- Human + AI Synergy: Pleio combines emotionally aware AI with peer-to-patient support to boost medication adherence.
- Overcoming Emotional Barriers: Emotions like fear, loneliness, and stigma are major challenges after diagnosis.
- Real-World Impact: Pleio's approach improved adherence rates by up to 28% in GLP-1 medication trials.
- Ethical AI in Healthcare: Patient data is de-identified and overseen by a medical board to ensure ethical use.
- Laser Focus on Loneliness: Pleio’s next frontier is tackling loneliness as a primary emotional barrier in healthcare.
To Learn More About Our Guest And Their Company:
Guest LinkedIn https://www.linkedin.com/in/michaeloleksiw/
Company LinkedIn https://www.linkedin.com/company/pleio-inc/
Website http://www.pleio.com
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.